Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Feb;5(1):6-12.
doi: 10.1111/os.12024.

Current concepts in the treatment of gouty arthritis

Affiliations
Review

Current concepts in the treatment of gouty arthritis

Zhen-hua Fang et al. Orthop Surg. 2013 Feb.

Abstract

Gouty arthritis is an extremely painful condition that causes functional impairment. Gouty arthritis has become increasingly complex because of multiple comorbidities, iatrogenic factors and hyperuricemia that is refractory to treatment. In this review, we present a general overview of gouty arthritis including its pathophysiology, clinical presentations, diagnosis, predisposing factors and prophylactic therapy for preventing gouty arthritis flares.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(A) Photographs of both feet of a male patient with gouty arthritis showing joint abnormalities and subcutaneous tophi (arrows) in multiple joints; and (B) Intraoperative photograph showing the presence of intracellular MSU crystals in a joint of the right foot.
Figure 2
Figure 2
An anteroposterior X‐ray film showing tophus formation and bone destruction of the first metatarsophalangeal joint in a female patient with gouty arthritis.

References

    1. Mikuls TR, Farrar JT, Bilker WB, Fernandes S, Schumacher HR Jr, Saag KG. Gout epidemiology: results from the UK General Practice Research Database, 1990–1999. Ann Rheum Dis, 2005, 64: 267–272. - PMC - PubMed
    1. Nuki G. Treatment of crystal arthropathy—history and advances. Rheum Dis Clin North Am, 2006, 32: 333–357. - PubMed
    1. McGonagle D, Tan AL, Shankaranarayana S, Madden J, Emery P, McDermott MF. Management of treatment resistant inflammation of acute on chronic tophaceous gout with anakinra. Ann Rheum Dis, 2007, 66: 1683–1684. - PMC - PubMed
    1. Choi HK, Curhan G. Independent impact of gout on mortality and risk for coronary heart disease. Circulation, 2007, 116: 894–900. - PubMed
    1. Rider TG, Jordan KM. The modern management of gout. Rheumatology (Oxford), 2010, 49: 5–14. - PubMed

MeSH terms

LinkOut - more resources